Dirk R. Wijnen schreef:
The rAd26 vaccine is the first HIV vaccine candidate that emerges
from the Integrated Preclinical/Clinical AIDS Vaccine Development
(IPCAVD) program, which brings together researchers from academia and
industry in an effort to accelerate the development of promising
HIV/AIDS vaccines.